Cargando…

Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?

Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly throughout the industrialized world. Its most prominent pathologic features are lesions involving the retinal pigment epithelium (RPE) the Bruch's membrane, the degeneration of photoreceptors, and, in the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Camelo, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022009/ https://www.ncbi.nlm.nih.gov/pubmed/24876950 http://dx.doi.org/10.1155/2014/532487

Ejemplares similares

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors
por: Camelo, Serge, et al.
Publicado: (2020)

Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji, Tsuyoshi, et al.
Publicado: (2013)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022)

Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD
por: Bhuiyan, Alauddin, et al.
Publicado: (2020)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
por: Kauppinen, Anu, et al.
Publicado: (2020)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016)

What effects has the cataract surgery on the development and progression of Age-Related Macular Degeneration (AMD)?
por: Bockelbrink, Angelina, et al.
Publicado: (2006)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
por: Pennington, Katie L., et al.
Publicado: (2016)

Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD)
por: Kaarniranta, Kai, et al.
Publicado: (2019)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Chemoprevention of age-related macular regeneration (AMD) with rapamycin
por: Zheng, X. F. Steven
Publicado: (2012)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
por: Muth, Daniel Rudolf, et al.
Publicado: (2022)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
por: Varano, Monica, et al.
Publicado: (2015)

Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions
por: Popp, Nicholas, et al.
Publicado: (2013)

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)
por: Tokarz, Paulina, et al.
Publicado: (2013)

Analysis of genetic polymorphisms for age-related macular degeneration (AMD) in Chinese Tujia ethnic minority group
por: Liu, Shengchun, et al.
Publicado: (2019)

MicroRNA Expression Analysis in Serum of Patients with Congenital Hemochromatosis and Age-Related Macular Degeneration (AMD)
por: Szemraj, Maciej, et al.
Publicado: (2017)

Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy
por: Laíns, Inês, et al.
Publicado: (2017)

A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care
por: Jalbert, Isabelle, et al.
Publicado: (2020)

Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design
por: de Koning-Backus, Alexandra P. M., et al.
Publicado: (2023)

Antioxidative Role of Heterophagy, Autophagy, and Mitophagy in the Retina and Their Association with the Age-Related Macular Degeneration (AMD) Etiopathogenesis
por: Nita, Małgorzata, et al.
Publicado: (2023)

Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management
por: Amini, Mohammad Amin, et al.
Publicado: (2023)

Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD)
por: Fontaine, Valérie, et al.
Publicado: (2023)

Vitrectomy in full thickness macular holes on top of a pigment epithelial detachment in age-related macular degeneration (AMD). Surgical consideration and review of the literature
por: Meyer, Paula S., et al.
Publicado: (2021)

Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bk9tt8flv4pjl8ate8p2gnfki4